We are live on
!
Find out more
MRCM
M&R Capital Management Portfolio holdings
AUM
$454M
1-Year Est. Return
40.11%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$414M
AUM Growth
+$32.3M
(+8.5%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
30.48%
Holding
216
New
11
Increased
89
Reduced
59
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$8.36M |
| 2 |
NOV
NOV
|
+$1.18M |
| 3 |
GNC
GNC Holdings, Inc.
GNC
|
+$936K |
| 4 |
Visa
V
|
+$812K |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$805K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$501K |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$380K |
| 3 |
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
|
+$326K |
| 4 |
Liberty Global Class A
LBTYA
|
+$282K |
| 5 |
Biogen
BIIB
|
+$280K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.03% |
| 2 | Miscellaneous | 15.33% |
| 3 | Financials | 12.38% |
| 4 | Industrials | 11.36% |
| 5 | Technology | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Abbott
ABT
$195B
| $1.01M | 0.24% |
26,224
-115
| -0.4% | -$4.43K |
|
77
Dentsply Sirona
XRAY
$2.22B
| $939K | 0.23% |
20,400
-750
| -4% | -$34.7K |
|
78
ConocoPhillips
COP
$157B
| $915K | 0.22% |
13,011
-93
| -0.7% | -$6.22K |
|
79
Mondelez International
MDLZ
$79.6B
| $910K | 0.22% |
26,352
-600
| -2% | -$20.5K |
|
80
Becton Dickinson
BDX
$51.6B
| $907K | 0.22% |
7,939
| – | – |
|
81
Caterpillar
CAT
$368B
| $893K | 0.22% |
8,989
-50
| -0.6% | -$4.71K |
|
82
HSBC
HSBC
$355B
| $891K | 0.22% |
20,340
| – | – |
|
83
iShares Biotechnology ETF
IBB
$10.5B
| $872K | 0.21% |
11,070
+330
| +3% | +$27.5K |
|
84
American Water Works
AWK
$27.5B
| $864K | 0.21% |
19,031
-25
| -0.1% | -$1.08K |
|
85
iShares Russell 1000 ETF
IWB
$49.1B
| $852K | 0.21% |
8,131
+80
| +1% | +$8.23K |
|
86
Automatic Data Processing
ADP
$114B
| $834K | 0.2% |
12,296
+114
| +0.9% | +$7.77K |
|
87
US Bancorp
USB
$97.3B
| $773K | 0.19% |
18,033
+500
| +3% | +$20.5K |
|
88
American International
AIG
$40.2B
| $770K | 0.19% |
15,395
+175
| +1% | +$8.7K |
|
|
WBA
89
DELISTED
Walgreens Boots Alliance
WBA
| $766K | 0.18% |
11,606
-1,000
| -8% | -$62.8K |
|
90
Intel
INTC
$473B
| $720K | 0.17% |
27,889
-1,171
| -4% | -$29.2K |
|
|
CMCSK
91
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $700K | 0.17% |
14,351
+872
| +6% | +$42.5K |
|
92
Home Depot
HD
$329B
| $687K | 0.17% |
8,680
+348
| +4% | +$27.7K |
|
93
Dollar General
DG
$27.1B
| $682K | 0.16% |
12,300
+8,800
| +251% | +$512K |
|
94
TotalEnergies
TTE
$191B
| $680K | 0.16% |
10,365
+340
| +3% | +$20.9K |
|
95
NCR Voyix
VYX
$1.21B
| $678K | 0.16% |
30,237
| – | – |
|
|
DD
96
DELISTED
Du Pont De Nemours E I
DD
| $670K | 0.16% |
10,517
+210
| +2% | +$12.8K |
|
97
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.07B
| $638K | 0.15% |
63,190
| – | – |
|
98
Amazon
AMZN
$2.87T
| $627K | 0.15% |
37,300
+10,100
| +37% | +$187K |
|
99
EOG Resources
EOG
$75.2B
| $624K | 0.15% |
6,360
| – | – |
|
|
WBK
100
DELISTED
Westpac Banking Corporation
WBK
| $603K | 0.15% |
18,800
| – | – |
|
Similar funds
EDRIA
SFP
AC
NIC
WCA
KC
SIGI
FPFS
M&R Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, M&R Capital Management held 216 positions worth $414M, up 8.5% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
M&R Capital Management deployed $27.9M of net new capital in Q1 2014, opening 11 new positions and adding to 89 existing holdings. Its largest new stake was Magellan Midstream Partners, L.P.: 5,800 shares worth $404K.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $501K trimmed.
- M&R Capital Management's largest Q1 2014 buy was Magellan Midstream Partners, L.P.: 5,800 shares worth $404K.
- M&R Capital Management added most to Allergan plc in Q1 2014, an estimated $8.36M increase.
- M&R Capital Management's biggest Q1 2014 reduction was Philip Morris, cutting an estimated $501K.
- M&R Capital Management fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $380K.
- M&R Capital Management's ten largest holdings make up 30% of its $414M portfolio in Q1 2014.
- M&R Capital Management opened 11 new positions and closed 8 in Q1 2014.
- M&R Capital Management's portfolio value rose 8.5% quarter-over-quarter to $414M.
Based on M&R Capital Management's 13F filing for Q1 2014, filed 2 May 2014.